XML 38 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 17 - Segment Reporting
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
17
– Segment Reporting
 
The Company
’s reportable segments are based on the internal reporting used by the Company’s CEO, who is the chief operating decision maker (CODM), to assess operating performance and make decisions about the allocation of resources. The Company’s reportable segments are based upon geographic region, consisting of the United States and Europe. The Corporate Unallocated and Japan category includes non-reportable segments, as well as research and development and general and administrative costs that are global in nature and that the Company does
not
allocate directly to its operating segments.
 
 
Revenue in the United States is derived
from Injection Molding, CNC Machining,
3D
Printing and Sheet Metal product lines. Revenue in Europe is derived from Injection Molding, CNC Machining, and
3D
Printing product lines. Revenue in Japan is derived from Injection Molding and CNC Machining product lines. Injection Molding revenue consists of sales of custom injection molds and injection-molded parts. CNC Machining revenue consists of sales of CNC-machined customer parts.
3D
Printing revenue consists of sales of
3D
-printed parts. Sheet Metal revenue consists of sales of fabricated sheet metal parts.
 
The accounting policies of the reportable segments are the same as those described in Note
2
 – Summary of Significant Accounting Policies. Intercompany transactions primarily relate to intercontinental activity and have been eliminated and are excluded from the reported amounts. The difference between income from operations and pre-tax income relates to foreign currency-related gains and losses and interest income on cash balances and investments, which are
not
allocated to business segments.
 
Revenue and income from operations by reportable segment are as follows:
 
       
   
Year Ended December 31,
 
(in thousands)
 
2017
   
2016
   
2015
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
United States
  $
263,086
    $
223,930
    $
208,018
 
Europe
   
70,154
     
63,365
     
47,433
 
Japan
   
11,250
     
10,760
     
8,655
 
Total revenue
  $
344,490
    $
298,055
    $
264,106
 
                         
 
   
Year Ended December 31,
 
(in thousands)
 
2017
   
2016
   
2015
 
Income from Operations:
 
 
 
 
 
 
 
 
 
 
 
 
United States
  $
103,136
    $
89,308
    $
86,450
 
Europe
   
12,846
     
11,657
     
13,304
 
Corporate Unallocated and Japan
   
(43,756
)    
(39,198
)    
(32,605
)
Total income from operations
  $
72,226
    $
61,767
    $
67,149
 
                         
 
Total long-lived assets, expenditures for additions to long-lived assets and depreciation and amortization expense are as follows:
 
                   
   
December 31,
   
December 31,
   
December 31,
 
(in thousands)
 
2017
   
2016
   
2015
 
Long-lived assets:
 
 
 
 
 
 
 
 
 
 
 
 
United States
  $
125,308
    $
108,650
    $
98,633
 
Europe
   
33,691
     
23,199
     
23,636
 
Japan
   
7,441
     
7,625
     
3,206
 
Total long-lived assets
  $
166,440
    $
139,474
    $
125,475
 
                         
 
       
   
Year Ended December 31,
 
(in thousands)
 
2017
   
2016
   
2015
 
Expenditures for additions to long-lived
assets:
 
 
 
 
 
 
 
 
 
 
 
 
United States
  $
20,370
    $
21,190
    $
32,560
 
Europe
   
11,704
     
5,954
     
10,396
 
Japan
   
561
     
6,472
     
1,406
 
Total expenditures for additions to long-lived assets
  $
32,635
    $
33,616
    $
44,362
 
                         
 
       
   
Year Ended December 31,
 
(in thousands)
 
2017
   
2016
   
2015
 
Depreciation and Amortization:
 
 
 
 
 
 
 
 
 
 
 
 
United States
  $
13,267
    $
12,533
    $
11,596
 
Europe
   
4,174
     
3,386
     
2,132
 
Japan
   
1,033
     
1,566
     
398
 
Total depreciation and amortization
  $
18,474
    $
17,485
    $
14,126
 
                         
 
The Company
’s revenue is derived primarily from its Injection Molding, CNC Machining,
3D
Printing and Sheet Metal product lines. Total revenue by product lines is as follows:
 
       
   
Year Ended December 31,
 
(in thousands)
 
2017
   
2016
   
2015
 
                         
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
Injection Molding
  $
194,432
    $
175,974
    $
163,387
 
CNC Machining
   
103,739
     
81,407
     
74,368
 
3D Printing
   
43,329
     
37,847
     
25,132
 
Sheet Metal
   
1,767
     
-
     
-
 
Other Product
   
1,223
     
2,827
     
1,219
 
Total revenue
  $
344,490
    $
298,055
    $
264,106